Taiwan FDA registration f61c675e8962d7dce04fba28daf6dec0
“QIAGEN” artus CMV RG PCR Kit
TW: “凱杰” 阿特斯巨細胞病毒核酸檢驗試劑套組
Taiwan·Risk Class 2·MD·QIAGEN GMBH·Registered Jun 05, 2015 – Jun 05, 2025ExpiredRegistration details
- Analysis ID
- f61c675e8962d7dce04fba28daf6dec0
- License Form
- Ministry of Health Medical Device Import No. 027347
- Customs Code
- DHA05602734702
Company information
- Manufacturer
- QIAGEN GMBH
- Manufacturer Country
- Germany
- Authorized Representative
- QIAGEN TAIWAN COMPANY LIMITED
Product details
- Intended Use
- This product is an in vitro nucleic acid amplification assay for the quantitative detection of CMV DNA in human plasma. This product uses polymerase chain reaction (PCR) technology and is used with a Rotor-Gene Q instrument.
- Product Type (Level 1)
- C Immunology and microbiology devices
- Product Type (Level 2)
- C3175 CMV serum reagent
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Jun 05, 2015
- Expiry Date
- Jun 05, 2025
About this record
Access comprehensive regulatory information for “QIAGEN” artus CMV RG PCR Kit in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number f61c675e8962d7dce04fba28daf6dec0 and manufactured by QIAGEN GMBH. The authorized representative in Taiwan is QIAGEN TAIWAN COMPANY LIMITED.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices